Improving Risk Assessment of AML With a Precision Genomic Strategy to Assess Mutation Clearance
Clinical trial NCT02756962 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT02756962
- Sponsor
- Washington University School of Medicine
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2016-07-06
- Primary completion
- 2029-07-31
- Enrollment
- 107
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.